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ABSTRACT 
Background: Management of postoperative pain after caesarean section (CS) requires a balance between pain relief 
and undesirable side effects of drugs and technique. In order to improve postoperative pain management after caesarean 
section, we compared intravenous patient controlled analgesia (IV-PCA) with our current hospital practice, which is 
continuous opioid infusion. Method: We enrolled one hundred and twenty patients in our prospective randomized trial 
after an uneventful elective caesarean section under spinal anaesthesia. All patients received 0.5 mg/kg bolus of 
pethidine on first complaint of pain or at 120 minutes after institution of spinal anaesthesia. Depending upon the ran-
domization, Group P received IV-PCA with 0.15 mg/kg bolus pethidine with 10-minute lockout and Group C received 
continuous pethidine infusion at a rate of 0.15 mg/kg/hr. Statistical Analysis: For qualitative variables means and stan-
dard deviations were computed and analyzed by T-test, Mann Whitney U test and repeated measures ANOVA. Fre-
quency and percentages were computed for qualitative data and analyzed by Chi-Square and Fischer exact test. A 
p-value of less than 0.05 was treated as significant. Results: The numeric rating score for pain, need for rescue analge-
sia and incidence of nausea and vomiting was significantly lower (p-value < 0.001) in IV-PCA group as compared to 
continuous infusion group at 6, 12 and 24 hours postoperatively, 98% of the patients were satisfied with pain manage-
ment in Group P as compared to 70% (p < 0.001) in Group C. Conclusion: Our results showed improved pain control, 
less need for rescue analgesia for breakthrough pain, lower incidence of nausea and vomiting and greater patient satis-
faction with IV-PCA. In the absence of preservative free narcotics for intrathecal use, postoperative pain management 
can be significantly improved by using IV-PCA instead of continuous opioid infusion in patients undergoing caesarean 
section. 
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1. Introduction 
Caesarean section (CS) commonly induces moderate to 
severe pain for about 48 hours. It requires optimal pe-
rioperative pain management; which not only allows the 
mother to ambulate early but also plays a key role in the 
postoperative rehabilitation after CS [1]. 
Intravenous patient controlled analgesia (IV-PCA) is 
now widely used in clinical practice, and is among the 
most recommended techniques for the control of moder-
ate to severe postoperative pain [2]. The devices used for 
IV-PCA are expensive and material costs per patients are 
usually higher compared with conventional analgesia [3]. 
Due to cost constraints, there is limited availability of 
IV-PCA devices in our hospital; therefore we have been 
using continuous opioid infusion as the alternate cost 
effective method for most of our CS patients. 
Several studies have compared the analgesic effects of 
different opioids using IV-PCA [4] and use of pethidine 
in patient controlled epidural analgesia (PCEA) versus 
IV-PCA [5]. However in spite of extensive literature 
search; we did not find any study which has compared 
continuous infusion and IV-PCA with pethidine in post 
caesarean patients. 
In our hospital setting there is a general perception 
among surgeons that adequate pain relief is achieved via 
continuous infusion. Our study question was to observe if 
our current hospital practice of pain management, which 
is continuous opioid infusion is providing adequate pain 
relief or needs to be replaced by some advanced modality 
like IV-PCA in patients undergoing elective caesarean 
section. Therefore the primary objective of this prospec-
tive randomized study was to assess if there are any 
clinical benefits of using IV-PCA compared to continu-
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ous opioid infusion using pethidine in terms of pain score. 
Our secondary objectives were to compare opioid con- 
sumption, need for rescue analgesia, patient satisfaction 
and side effects between the two groups. 
2. Materials and Methods 
In this randomized controlled prospective study, we ob- 
tained approval from the hospital ethics committee, to 
study 120 American Society of Anesthesiologists (ASA) 
physical status I & II parturient at term having healthy 
fetuses, undergoing elective caesarean section under spi- 
nal anaesthesia. Exclusion criteria were: patients allergic 
to study drugs, surgery exceeding more than 90 minutes, 
women having additional procedures like tubal ligation, 
women having chronic pain syndromes, on long term 
analgesic medications and patients refusing to participate 
in the study. All patients fulfilling the inclusion criteria 
and scheduled for elective CS under spinal anaesthesia 
were asked for written, informed consent before surgery. 
Once they consented to participate in the study and 
signed the written informed consent, they were instructed 
on numeric rating scale (NRS) for pain assessment with 
zero being no pain and 10 representing worst pain imag-
inable. As blinding was not possible in this study, we 
made sure that all assessment, data collection and docu-
mentation in the form was done by the acute pain man-
agement service (AMPS) nurse who was otherwise not a 
part of the study project. Primary outcome of our study 
was pain control assessed by numeric rating scale and 
secondary outcomes were opioid consumption, need for 
rescue analgesia and incidence of side effects. Assess-
ments for pain (rest and movement) and of side effects 
were done according to the set APMS protocol of our 
hospital setting. 
All patients received standard spinal anaesthesia in the 
sitting position with a 25 gauge pencil point spinal needle 
with introducer, after local infiltration of skin with 2 - 3 
ml of 2% lignocaine. We used 10 mg of 0.5% isobaric 
bupivacaine with 25 mcg of fentanyl for intrathecal in-
jection. Surgery was allowed to start after establishment 
of block up to T4 to T5 level. After successful comple-
tion of surgery, patients were shifted to recovery room 
(RR) and were monitored by a RR nurse. All patients 
who had uneventful surgery which finished within 90 
minutes were enrolled in the study. All the enrolled pa-
tients had already given written informed consent before 
surgery. Patients were randomized by drawing shuffled 
coded envelopes to receive one of the two analgesic 
regimens. There were 120 coded sealed opaque enve-
lopes which were prepared by the primary investigator. 
60 envelops contained the code “IV-PCA” and 60 con-
tained the code “Continuous Infusion”. The envelopes 
were shuffled every time before drawing the envelope for 
each patient.  
On patient’s first complaint of pain, or 120 minutes 
after the institution of spinal anaesthesia, (whichever 
came first) a loading dose of 0.5 mg/kg of pethidine was 
given over 2 minutes. Depending upon the randomization, 
patients were either attached to IV-PCA pumps (Graseby 
3300 PCA pumps manufactured by SIMS Graseby lim-
ited, Watford Herts UK) or continuous infusion by 
volumetric pumps (Volumed µVP 5005 acromed Swit-
zerland) after 15 minutes of the loading dose.  
In continuous infusion group, pethidine infusion was 
started at a rate of 0.15 mg/kg/hour and was continued 
for 24 hrs. In IV-PCA group, an IV-PCA pump was at-
tached to the patient with no background infusion and 
bolus of 0.15 mg/kg body weight with lockout interval of 
10 minutes. 
NRS for pain was assessed by the nurse from the acute 
pain management service (APMS), who was otherwise 
not a part of the study project. NRS was assessed in two 
different ways; one at rest and the other at movement 
where patient was asked to bend her knees. Patient’s pain 
was assessed on arrival in the RR, at 120 minutes of spi-
nal anaesthesia and 5, 15 and 30 minutes after giving the 
bolus and attaching one of the two pain regimes by one 
of the investigator. When a patient fulfilled all discharge 
criteria, she was shifted to the ward where she was as-
sessed for pain at 6, 12 and 24 hours by the acute pain 
management service (APMS). Besides the APMS, ward 
nurses checked and recorded the NRS every 4 hours as 
per hospital protocol. APMS and ward nurses were in-
formed about the study protocol, data collection and 
documentation in the study form. The data collected was 
reviewed separately by two investigators on the first 
postoperative day for any missing entries and was sub-
mitted to the statistician for data entry. 
Patients in both groups were instructed to call the 
nurse for rescue analgesia if pain relief was not adequate 
(NRS > 3). Rescue analgesia was provided according to 
the written orders for postoperative pain management. 
First line of rescue analgesia was pethidine 10 mg IV stat 
(total 30 mg). If a patient still complained of pain after 
30 minutes of three doses of 10 mg of pethidine, second 
line of rescue analgesia was provided with 2 mg of IV 
morphine. Rescue analgesia was repeated every 20 min-
utes, till the patient was completely pain free. All patients, 
irrespective of the group were assessed for the need of 
rescue analgesia and the drug, dose and timings were 
noted in the study form by the nurse from APMS. 
Patients were assessed for side effects both in the RR 
and the ward. Postoperative nausea and vomiting (PONV) 
was measured with the help of scoring system used by 
the set APMS protocol, where 0 was no PONV, 1 was 
mild nausea on inquiry, 2 was nausea without inquiry, 3 
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was vomiting and 4 was severe repeated vomiting. Seda-
tion score ranged from 1 to 5, where 1 was alert and 5 
was denoted to patient in deep sleep. Pruritus, drop in 
oxygen saturation and respiratory rate less than 10 were 
other complications noted. These were recorded by the 
ward nurses, who were informed about the study protocol 
and its documentation. All adverse effects were to be 
managed according to hospital protocol and included in 
our results. 
All patients were prescribed injection metoclopramide 
10 mg I/V stat 8 hourly and tablet paracetamol 1 gram 
three times a day and diclofenac suppository 100 mg 
twice a day. 
APMS team on the first postoperative day interviewed 
the patient for their satisfaction with postoperative pain 
management therapy and whether they would like to 
have the same pain management therapy for the future 
surgeries. 
3. Results 
We studied 120 patients, 60 in each group. The groups 
matched for age, weight, height, BMI and previous cae-
sarean sections (Table 1). All patients received the same 
dose of intraoperative anaesthesia and analgesia (Bupiva-
caine 10 mg and fentanyl 25 mcg) and the duration of all 
surgeries was less than 90 minutes. The surgical tech-
nique was same and uterus was exteriorized for stitching 
in all cases. 
The NRS for pain at rest and movement in the RR was 
one or less for both groups and no significant differences 
were observed within groups or between groups at dif-
ferent times. The NRS at rest and movement for con-
tinuous infusion group at 6, 12 and 24 hours postopera-
tively was significantly higher compared to IV-PCA 
group (p < 0.001) (Figures 1 and 2). Number of patients 
in IV-PCA group and continuous infusion group having 
different severity of pain score measured at 6, 12 and 24 
hours in the postoperative period at rest and movement is 
shown in Tables 2 and 3. There was a gradual increase in 
NRS from 6 to 12 hours and then a gradual decline from 
12 to 24 hours. None of the patients in either group had 
NRS of more than 7. 
None of the patients in either group had drop in oxy-
gen saturation or respiratory rate less than 10. There was 
no difference in the incidence of vomiting; however in-
cidence of nausea (score 1 & 2) was significantly higher 
between 6 and 12 hours in continuous infusion group 
compared to IV-PCA group (p < 0.001). 
In the IV-PCA group, nine (14.8%) patients required 
rescue analgesia as compared to 42 (70%) in continuous 
infusion group which was significantly higher as com-
pared to IV-PCA group (p < 0.001). The need for rescue 
analgesia was mostly between 6 - 12 hours postopera-
tively. None of the patients in either group required 
morphine as pain was relieved with three doses or less of 
10 mg pethidine, every time rescue analgesia was re-
quired. A total of 13 patients required rescue analgesia 
more than once during the study period (2 patients from 
IV-PCA group and eleven patients were from continuous 
infusion group). In IV-PCA group, the mean of demand 
made on PCA was 36.2 (SD 11.91) and mean of suc-
cessful demands were 31.52 (SD 10.89). 
There was no significant difference between the total 
amounts of pethidine consumed over 24 hours between 
the two groups (360 mg in IV-PCA group versus 363 mg 
in continuous group). Ninety eight percent of the patients 
were satisfied with pain management and wanted the 
same form of analgesia for future surgeries in the IV- 
PCA group as compared to 70% in continuous infusion 
group (p < 0.001). 
 
Table 1. Characteristics of patients receiving pethidine via 
continuous infusion (Group C) or patient controlled intra-
venous technique (Group P). Values refer to mean (SD). 
Variables Group C Group P p value 
Age (yrs) 27 (3.58) 27 (3.95) 0.72 
Weight (kg) 71 (6.79) 72 (6.32) 0.43 
Height (cm) 159 (5.26) 158 (5.38) 0.25 
BMI (kg/m2) 28 (3.18) 29 (3.30) 0.17 
Previous CS 63% 62% 0.50 
 
 
Figure 1. Verbal rating score (VRS) for pain on movement 
for Group P & Group C for different times in the postop-
erative period *p < 0.001. 
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Figure 2. Verbal rating score (VRS) for pain on movement 
for Group P & Group C for different times in the postop-
erative period *p < 0.001. 
 
Table 2. Number of patients (%) having different pain 
scores on rest at 6, 12 and 24 hours post operatively receiv-
ing pethidine via patient control intravenous (Group P) or 






(n = 60) 
Group C 
(n = 60) p value
NRS 1-3 60 (100%) 55 (95%) 
NRS 4-6 0 (0%) 5 (5%) 6 hrs 
NRS 7† 0 (0%) 0 (0%) 
0.57
NRS 1-3 60 (100%) 33 (55.7%)
NRS 4-6 0 (0%) 26 (42.6%)12 hrs 
NRS 7† 0 (0%) 1 (1.6%) 
<0.01*
NRS 1-3 60 (100%) 57 (95%) 
NRS 4-6 0 (0%) 3 (5%) 24 hrs 
NRS 7† 0 (0%) 0 (0%) 
0.244
€NRS: Numeric rating scale; †None of the patient having severe pain had 
numeric rating score (NRS) of more than 7; *p < 0.05. 
4. Discussion 
In this study we demonstrated that using pethidine by IV- 
PCA gave better pain scores at 6, 12 and 24 hours post-
operatively compared to continuous intravenous pethidine 
infusion after elective caesarean section with an accept-
able side effect profile. Although the pain scores were 
better and the need for rescue analgesia was less in  
Table 3. Number of patients (%) having different pain 
scores on movement at 6, 12 and 24 hours post operatively 
receiving pethidine via patient control intravenous (Group 






(n = 60) 
Group C 
(n = 60) p value
NRS 1-3 58 (96.7%) 32 (53.3%)
NRS 4-6 2 (3.3%) 27 (45%) 6 hrs 
NRS 7† 0 (0%) 1 (1.7%) 
p < 0.01*
NRS 1-3 58 (96.7%) 29 (48.3%)
NRS 4-6 2 (3.3%) 25 (41.7%)12 hrs 
NRS 7† 0 (0%) 6 (10%) 
p < 0.01*
NRS 1-3 58 (96.7%) 55 (91.7%)
NRS 4-6 2 (3.3%) 5 (8.3%) 24 hrs 
NRS 7† 0 (0%) 0 (0%) 
0.219 
€NRS: Numeric rating scale; †None of the patient having severe pain had 
numeric rating score (NRS) of more than 7; *p < 0.05. 
 
IV-PCA group, the amount of pethidine consumed was 
similar in the two groups. 
PCA works on the principle of individual variability of 
“what you need is what you get” (WYNIWYG) [6]. 
Since the total amount of pethidine consumed over 24 
hours was the same in both groups, one explanation for 
improved pain control with PCA could be the timing of 
the doses. Patients’ own control over their pain manage-
ment may have allowed them to obtain an opioid bolus at 
the initial feeling of pain, without having to wait for the 
nurses and doctors to provide analgesia, resulting in 
overall improved analgesia. The optimal bolus dose in 
PCA is controversial. Owen et al. [7] studied the effect 
of different doses of morphine (0.5, 1 and 2 mg) and 
found that 1 mg (0.01 - 0.02 mg/kg) was the optimal bo-
lus PCA dose. Therefore we chose 0.15 mg/kg (average 
10 - 15 mg) bolus dose of pethidine, considering an an-
algesic potency one tenth that of morphine. 
Various studies [8-10] using continuous opioid infu-
sion (either as a fixed dose or dose based on weight) have 
failed to identify an ideal dose that would provide ade-
quate analgesia during rest and activity without supple-
mental bolus doses and prevent side effects [11]. We 
used a fixed dose of pethidine according to the weight of 
patient (0.5 mg/kg bolus followed by 0.15 mg/kg con-
tinuous infusion per hour), as this is the routine practice 
and kept the option of rescue analgesia for patients hav-
ing inadequate pain relief. 
We found a statistically significant difference between 
the need for rescue analgesia between the two groups. 
The need for rescue analgesia was mostly between 6 - 12 
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hours postoperatively. The NRS at rest and movement 
showed a rising trend and was found to be highest at 12 
hours and then a declining trend was observed. Some-
what similar observations were made in the study of Al-
hashemi et al. [12] where they found a peak of morphine 
requirement between 4 - 8 hours. The gradual increase in 
NRS score and rescue analgesia during this time could be 
explained by the recession of spinal anaesthesia and pa-
tients’ mobilization. This was the time when 8 patients 
complained of severe pain, all from continuous infusion 
group but none of the patients had NRS of more than 
seven. In all patients NRS came to 1 - 3 after 10 - 15 
minutes of giving rescue analgesia and none of the pa-
tients required morphine which was our second line of 
rescue analgesia. However 13 patients did require rescue 
analgesia more than twice during the study period. We 
kept morphine as our second line of analgesic, largely 
because we needed a stronger analgesic for patients in 
whom pain would not be relieved by pethidine. As in our 
country morphine is only available in limited amount we 
could not use it as our primary analgesic agent. 
Even with the increased use of rescue analgesia, the 
amount of pethidine consumed during the study period 
remained the same in the two groups. This is contrary to 
a previous study done in a group of sickle cell disease 
patients in whom lower mean morphine consumption in 
the PCA group resulted in adequate pain relief and sig-
nificantly less nausea and vomiting compared with the 
continuous infusion group during vaso-occlusive crises 
[13]. Recently this trend has changed, as consumption 
has been found to be equal or more compared to con-
tinuous infusion depending upon individual variability 
[6]. The fact that the amount of pethidine consumed was 
same in the two groups indicates the advantage offered to 
IV-PCA group patients, to take the dose of analgesia at 
the initial feeling of pain, leading to an improved analge-
sic profile with the same amount of opioid utilized. 
Postoperative adverse events were minor in our study 
and consisted mainly of nausea and vomiting which was 
found more in continuous infusion group between 6 and 
12 hrs. PONV is often associated with postoperative pain 
and its treatment [14] and we observed that it occurred at 
the time when patient had breakthrough pain and was 
given rescue boluses of pethidine. 
We had prescribed metoclopramide routinely for every 
patient as per departmental protocol. Studies have proved 
that metoclopramide is ineffective in reducing the inci-
dence and the severity of PONV [15]. The nausea and 
vomiting in our patients seems likely to be due to post-
operative pain and its treatment and also due to the fact 
that multimodal anti-emetic was only administered on 
demand and not prophylactically on risk demand assess-
ment [16]. 
The level of satisfaction was found to be higher in the 
IV-PCA group. It has been shown previously that effects 
of intravenous patient controlled analgesia and conven-
tional intermittent or continuous opioid analgesia on in-
testinal function; recovery and length of hospital stay are 
nearly the same. However, patients using IV-PCA are 
more satisfied with their surgery and hospitalization than 
those who receive the conventional pain relief methods 
[17]. The benefit of PCA for the patient stems from 
prompt delivery of the analgesic, reducing the time be-
tween pain occurrence and drug administration [18,19].  
Although morphine remains the most important anal-
gesic used in the management of postoperative pain [20], 
we used pethidine for both PCA and continuous infusion 
in our study. Developing countries face an acute shortage 
of opioids. Morphine is available in a very limited 
amount and pethidine is mostly used for postoperative 
pain management. In the literature, superior pain relief 
with morphine compared to pethidine has been demon-
strated in two studies [21,22], while other studies have 
failed to show any superiority of morphine [23,24]. In 
one study [25] PCA morphine and pethidine were equally 
effective for controlling postoperative pain and had 
similar side effects. Like any other opioid, pethidine is 
associated with certain unwanted effects, both for the 
mother and the newborn. The American Academy of 
Pediatrics Committee on Drugs labels pethidine in cate-
gory 3 (compatible with breast feeding) [26]. This state-
ment however comes with recommendation that infants 
should be watched for signs and symptoms of pethidine 
accumulation. In our study, we did not plan to observe 
the neonatal effects of pethidine in these breast feeding 
mothers, which is one of the limitations of our study. 
Another limitation of our study is the use of pethidine 
as our primary analgesic agent, as pethidine is no longer 
used in many parts of the world for postoperative analge-
sia. Still there are many developing countries which are 
using pethidine like, one study done in rural health dis-
trict of South Africa [27] has shown pethidine as the 
most common opioid prescribed (69% of the patients) 
after CS and intramuscular route was the only route of 
administration. Our study in spite of this limitation can 
be helpful to many readers from the developing countries 
that are still faced with the limited availability of the 
opioids. 
One of the other limitations of our study was our in-
ability to do blinding. Since NRS for pain, need for res-
cue analgesia, total opioid consumption over 24 hours 
and observation of side effects in both groups were re-
quired to be assessed and documented, it was not possi-
ble to blind the assessor to the treatment group. We tried 
to remove the element of bias by assigning the pain 
nurses from AMPS who are trained and as part of their  
Copyright © 2012 SciRes.                                                                               OJAnes 
Postoperative Analgesia Following Caesarean Section: Intravenous Patient Controlled Analgesia 
versus Conventional Continuous Infusion 
125
job description routinely do assessment for every post-
operative patient under the APMS service. The AMPS 
nurses who were assessing, documenting and following 
the orders according to the protocol were not part of the 
research project. Two of the investigators after checking 
the pro forma for its completeness handed it over to the 
research officer for data entry. 
We have used co-analgesics in our study, as patients in 
both group received diclofenac rectally every 8 hours and 
paracetamol orally every 6 hours. Siddik SM and col- 
leagues [28] in their study have found improved analge- 
sia and morphine sparing effect with the use of rectal 
diclofenac but they used intravenous paracetamol instead 
of oral. 
Since we have obtained clearly positive results in fa-
vour of IV-PCA, we plan to share our results with the 
hospital administration and highlight the importance of 
obtaining IV-PCA pumps and thus slowly build up our 
resources in an endeavor to improve postoperative pain 
management after cesarean section in our patient popula-
tion. 
Since we have erratic and limited supply of opioids in 
our country, we can utilize other recourses including in-
travenous paracetamol [7] multimodal techniques like 
local analgesia, non-steroidal anti-inflammatory cocktail 
wound infiltration and abdominal nerve blocks as ad-
juncts [29] to postoperative analgesic regimes. This 
would benefit our caesarean section patients in reducing 
opioid consumption while providing better pain relief.  
In conclusion postoperative pain management was 
found to be better with IV-PCA as compared to continu-
ous opioid infusion. We need to promote IV-PCA in de-
veloping countries for the better pain control and patient 
satisfaction. We also believe that issue of cost and avail-
ability of drugs remains a challenge for effective pain 
management in developing countries. However we need 
to explore the possibility of enhancement of postopera-
tive pain relief methods through alteration in the standard 
methods. 
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